Global transport and logistics provider GEODIS has officially expanded its European cold-chain capabilities with the opening of a state-of-the-art, temperature-controlled pharmaceutical logistics hub in Manchester, UK. The newly commissioned facility, located at the Sharston Green Business Park in South Manchester, provides approximately 2,000 high-density pallet positions dedicated exclusively to pharmaceutical, biopharmaceutical, and healthcare products requiring strict thermal management.
The launch of the Manchester hub comes at a pivotal time for the global life sciences sector, as the volume of temperature-sensitive biologics, advanced therapies, and clinical trial supplies continues to grow exponentially. Positioned near Manchester Airport and major UK motorway arteries, the strategic facility is designed to optimize both domestic distribution and international air/sea freight routes, including critical trade lanes connecting to Ireland's biopharmaceutical manufacturing hubs in Dublin, Cork, and Shannon.
Advanced Multi-Temperature Infrastructure
Maintaining strict thermal integrity throughout the storage and transport cycle is mandatory under international healthcare regulations. GEODIS's new Manchester site has been engineered with dual-zone climate controls to support a broad spectrum of pharmaceutical storage requirements:
- Controlled Room Temperature (CRT): A spacious 15°C to 25°C environment designed for standard pharmaceuticals, tablet formulations, and specialized medical devices.
- Chilled Storage: A dedicated 2°C to 8°C cold room engineered for temperature-sensitive biologics, vaccines, and injectable therapies.
- Future Deep-Freeze Capability: The facility infrastructure is pre-configured to accommodate ultra-low temperature (ULT) freezer units (-20°C to -80°C), positioning the hub to handle future cell and gene therapy demands.
To guarantee strict compliance, the warehouse features 24/7 automated continuous temperature and humidity monitoring systems. Redundant backup power generators and real-time digital alert protocols ensure that any environmental fluctuations are detected and corrected instantly, preventing product degradation or loss.
Full GDP Compliance and Regulatory Certifications
Operating in the healthcare supply chain requires strict adherence to quality and safety standards. The Manchester facility operates under full Good Distribution Practice (GDP) compliance and holds a formal Wholesale Distribution Authorisation (WDA) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).
In addition to GDP and WDA accreditations, the facility has achieved a comprehensive suite of international quality, environmental, and security certifications:
- ISO 9001 (Quality Management): Standardizing operational workflows and customer service protocols.
- ISO 14001 (Environmental Management) & ISO 50001 (Energy Management): Incorporating energy-efficient climate control technology to minimize carbon emissions.
- ISO 45001 (Occupational Health & Safety): Ensuring maximum workplace safety for logistics personnel.
- TAPA & AEO (Security & Customs Compliance): Authorised Economic Operator (AEO) status and Transported Asset Protection Association (TAPA) compliance ensure expedited customs clearance and maximum security for high-value drug cargos.
Strategic Connectivity to Ireland and Global Markets
The geographic location of the Sharston Green facility provides a key logistical advantage. Situated immediately adjacent to the M6 and M62 motorway corridors and minutes from Manchester Airport's international cargo terminal, the hub enables rapid transit to major ports and airports across the UK and Europe.
For Irish biopharmaceutical manufacturers, Manchester represents a vital transit node. Ireland exports over €139 billion in pharmaceutical products annually, with a vast portion of these shipments transiting through Irish Sea freight routes to the UK mainland before connecting to broader European and Asian distribution networks. The GEODIS Manchester hub offers cross-docking, short-term holding, inventory management, and specialized returns handling, providing Irish and global pharma manufacturers with a secure, GDP-certified staging area.
Meeting Rising Demand for Cold-Chain Logistics
The opening of the Manchester facility reflects GEODIS's broader global commitment to expanding its specialized healthcare and life sciences footprint. As pharmaceutical pipelines increasingly pivot toward complex biologic drugs, mRNA vaccines, and personalized medicine, the demand for certified cold-chain warehousing has significantly outpaced traditional logistics capacity.
By combining advanced multi-temperature storage, 24/7 digital monitoring, and seamless multimodal transportation connectivity, GEODIS's new Manchester hub sets a high benchmark for pharmaceutical logistics excellence, ensuring that life-saving healthcare products reach patients worldwide without compromise.
